538 related articles for article (PubMed ID: 18461922)
41. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
[TBL] [Abstract][Full Text] [Related]
42. Selected gold compounds cause pronounced inhibition of Falcipain 2 and effectively block P. falciparum growth in vitro.
Micale N; Cinellu MA; Maiore L; Sannella AR; Severini C; Schirmeister T; Gabbiani C; Messori L
J Inorg Biochem; 2011 Dec; 105(12):1576-9. PubMed ID: 22071081
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids.
Singh V; Hada RS; Uddin A; Aneja B; Abid M; Pandey KC; Singh S
Curr Top Med Chem; 2020; 20(5):377-389. PubMed ID: 32000644
[TBL] [Abstract][Full Text] [Related]
44. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
45. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
Singh A; Rosenthal PJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum.
Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA
Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.
Biot C; Pradines B; Sergeant MH; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2007 Dec; 17(23):6434-8. PubMed ID: 17949976
[TBL] [Abstract][Full Text] [Related]
48. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
[TBL] [Abstract][Full Text] [Related]
49. Dipeptide vinyl sultams: synthesis via the Wittig-Horner reaction and activity against papain, falcipain-2 and Plasmodium falciparum.
Valente C; Guedes RC; Moreira R; Iley J; Gut J; Rosenthal PJ
Bioorg Med Chem Lett; 2006 Aug; 16(15):4115-9. PubMed ID: 16697641
[TBL] [Abstract][Full Text] [Related]
50. Falcipain-2 inhibitors.
Ettari R; Bova F; Zappalà M; Grasso S; Micale N
Med Res Rev; 2010 Jan; 30(1):136-67. PubMed ID: 19526594
[TBL] [Abstract][Full Text] [Related]
51. Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors.
Rizzi L; Sundararaman S; Cendic K; Vaiana N; Korde R; Sinha D; Mohmmed A; Malhotra P; Romeo S
Eur J Med Chem; 2011 Jun; 46(6):2083-90. PubMed ID: 21429631
[TBL] [Abstract][Full Text] [Related]
52. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
53. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.
Sijwali PS; Rosenthal PJ
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4384-9. PubMed ID: 15070727
[TBL] [Abstract][Full Text] [Related]
54. Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2.
Pandey KC; Sijwali PS; Singh A; Na BK; Rosenthal PJ
J Biol Chem; 2004 Jan; 279(5):3484-91. PubMed ID: 14625277
[TBL] [Abstract][Full Text] [Related]
55. Antimalarial activities of novel synthetic cysteine protease inhibitors.
Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate.
Gelhaus C; Vicik R; Hilgenfeld R; Schmidt CL; Leippe M; Schirmeister T
Biol Chem; 2004 May; 385(5):435-8. PubMed ID: 15196005
[TBL] [Abstract][Full Text] [Related]
57. Falcipain cysteine proteases of malaria parasites: An update.
Rosenthal PJ
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
[TBL] [Abstract][Full Text] [Related]
58. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.
Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M
ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258
[TBL] [Abstract][Full Text] [Related]
60. Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells.
Gelhaus C; Vicik R; Schirmeister T; Leippe M
Biol Chem; 2005 May; 386(5):499-502. PubMed ID: 15927894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
